Blunted Hypercapnic Respiratory Drive Response in Subjects With Late-Onset Pompe Disease

Abstract

BACKGROUND:

Patients with late-onset Pompe disease develop progressive hypercapnic respiratory failure that can be disproportionate to the respiratory muscle compromise and/or thoracic restriction. Although recent studies have reported the presence of a blunted hypercapnic respiratory response in some subjects with neuromuscular disorders and chronic hypercapnia, no study has evaluated the integrity of the respiratory drive in subjects with late-onset Pompe disease. Thus, we endeavor to determine the CO₂ rebreathing response in subjects with late-onset Pompe disease.

METHODS:

Respiratory muscle strength was assessed by measuring the maximum inspiratory pressure, and the maximum expiratory pressure. The maximum inspiratory pressure reflects the strength of the diaphragm and other inspiratory muscles, whereas the maximum expiratory pressure reflects the strength of the abdominal muscles and other expiratory muscles. We studied the hypercapnic drive response (measured as the ratio of the change in airway-occlusion pressure 0.1 s after the start of inspiration and end-tidal P_CO₂ in 13 subjects with late-onset Pompe disease and 51 healthy controls.

RESULTS:

Overall inspiratory muscle strength was within normal limits or slightly diminished in the late-onset Pompe disease group. Five subjects (38.5%) were chronically hypercapnic, and 9 (69.2%) had an increased breath-holding time. Compared with controls, the change in airway-occlusion pressure 0.1 s/change in end-tidal CO₂ pressure slope (hypercapnic respiratory drive) was lower in the late-onset Pompe disease group (median 0.050 [interquartile range 0.027–0.118] vs 0.183 [0.153–0.233], P < .001). Nine subjects (69.2%) had a blunted change in airway-occlusion pressure 0.1 s/change in end-tidal carbon dioxide pressure slope.

CONCLUSIONS:

Subjects with late-onset Pompe disease had an impaired hypercapnic respiratory drive response. The clinical impact of this phenomenon in this subject subset deserves further investigation.

Keywords

late-onset Pompe disease control of breathing hypercapnic respiratory drive central chemoreception hypercapnia respiratory under responsiveness to hypoxia and hypercapnia

Get full access to this article

View all access options for this article.

References

Di Rocco

, Buzzi

, Tarò

. Glycogen storage disease type II: clinical overview. Acta Myol, 2007; 26(1):42–44.

ACMG Work Group on Management of Pompe Disease, Kishnani

, Steiner

, Bali

, Berger

, Byrne

, et al. Pompe disease diagnosis and management guideline. Genet Med, 2006; 8(5):267–288.

Aruj

, Monteiro

, De Vito

. [Analysis of factors associated with chronic hypercapnia in patients with myotonic dystrophy]. Medicina, 2013; 73(6):529–534.

Raurich

, Rialp

, Llompart-Pou

, Ayestarán

, Pérez-Bárcena

, Ibáñez

. Respiratory CO(2) response in acute cervical spinal cord injury (CO(2) response in spinal cord injury). Spinal cord, 2014; 52(1):39–43.

Whitelaw

, Derenne

, Milic-Emili

. Occlusion pressure as a measure of respiratory center output in conscious man. Respir Physiol, 1975; 23(2):181–199.

Whitelaw

, Derenne

. Airway occlusion pressure. J Appl Physiol, 1993; 74(4):1475–1483.

Evans

, Whitelaw

. The assessment of maximal respiratory mouth pressures in adults. Respir Care, 2009; 54(10):1348–1359.

Learn & Master ACLS. ACLS-algorithms.com. Quantitative Waveform Capnography. https://acls-algorithms.com/waveform-capnography/.

Mitrouska

, Tsoumakidou

, Prinianakis

, Milic-Emili

, Siafakas

. Effect of voluntary respiratory efforts on breath-holding time. Respir Physiol Neurobiol, 2007; 157(2):290–294.

10.

Bégin

, Bureau

, Lupien

, Lemieux

. Control and modulation of respiration in Steinert's myotonic dystrophy. Am Rev Respir Dis, 1980; 121(2):281–289.

11.

Holle

, Schoene

, Pavlin

. Effect of respiratory muscle weakness on P0.1 induced by partial curarization. J Appl Physiol, 1984; 57(4):1150–1157.

12.

Baydur

. Respiratory muscle strength and control of ventilation in patients with neuromuscular disease. Chest, 1991; 99(2):330–338.

13.

Bégin

, Bureau

, Lupien

, Lemieux

. Control of breathing in Duchenne's muscular dystrophy. Am J Med, 1980; 69(2):227–234.

14.

Carroll

, Zwillich

, Weil

. Ventilatory response in myotonic dystrophy. Neurology, 1977; 27(12):1125–1128.

15.

Tantucci

, Massucci

, Piperno

, Betti

, Grassi

, Sorbini

. Control of breathing and respiratory muscle strength in patients with multiple sclerosis. Chest, 1994; 105(4):1163–1170.

16.

Matecki

, Petrof

. Respiratory consequences of neuromuscular disease. In: Hamid

, Martin

, editors. Physiologic basis of respiratory disease. Hamilton, Ontario, Canada: BC Decker; 2005:319–329.

17.

Braun

, Arora

, Rochester

. Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax, 1983; 38(8):616–623.

18.

Borel

, Teitelbaum

, Hanley

. Ventilatory drive and carbon dioxide response in ventilatory failure due to myasthenia gravis and Guillain-Barre syndrome. Crit Care Med, 1993; 21(11):1717–1726.

19.

Johnson

, Kazemi

. Central control of ventilation in neuromuscular disease. Clin Chest Med, 1994; 15(4):607–617.

20.

Carroll

, Zwillich

, Weil

, Brooke

. Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology, 1976; 26(2):140–146.

21.

Kazemi

. Cerebrospinal fluid and the control of ventilation. In: Crystal

, West

, Weibel

, Barnes

, editors. The lung: scientific foundations, 2nd edition. Philadelphia: Lippincott-Raven Publishers; 1997:1777.

22.

Kazemi

, Shore

, Shih

, Shannon

. Brain organic buffers in respiratory acidosis and alkalosis. J Appl Physiol, 1973; 34(4):478–482.

23.

Park

. Respiratory control in chronic obstructive pulmonary diseases. Clin Chest Med, 1980; 1(1):73–84.

24.

Irsigler

, Stafford

, Severinghaus

. Relationship of CSF pH, O₂, and CO₂ responses in metabolic acidosis and alkalosis in humans. J Appl Physiol, 1980; 48(2):355–361.

25.

Oren

, Whipp

, Wasserman

. Effects of chronic acid-base changes on the rebreathing hypercapnic ventilatory response in man. Respiration. 1991; 58(3):181–185.

26.

Linton

, Poole-Wilson

, Davies

, Cameron

. A comparison of the ventilatory response to carbon dioxide by steady-state and rebreathing methods during metabolic acidosis and alkalosis. Clin Sci Mol Med, 1973; 45(2):239–249.

27.

Fuller

, ElMallah

, Smith

, Corti

, Lawson

, Falk

, Byrne

. The respiratory neuromuscular system in Pompe disease. Respir Physiol Neurobiol, 2013; 189(2):241–249.

28.

Falk

, Mah

, Soustek

, Lee

, Elmallah

, Cloutier

, et al. Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease. Mol Ther, 2013; 21(9):1661–1667.

29.

Kishnani

, Beckemeyer

, Mendelsohn

. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management. Am J Med Genet C Semin Med Genet, 2012; 160C(1):1–7.

30.

Wirsching

, Müller-Felber

, Schoser

. Are evoked potentials in patients with adult-onset Pompe disease indicative of clinically relevant central nervous system involvement?. J Clin Neurophysiol, 2014; 31(4):362–366.